Utility of antidiabetes medications in chronic kidney disease

A review

Emily Knezevich, Annette Kueser

Research output: Contribution to journalReview article

1 Citation (Scopus)

Abstract

There is a large body of evidence describing the utility of antidiabetes agents in people with chronic kidney disease (CKD). Clinical decisions should take into account the pharmacokinetic variability and potential adverse events seen when these agents are used in renally impaired patients. In this article, the authors review the literature and summarise which antidiabetes agents are safe, with dose reductions if necessary, in people with CKD.

Original languageEnglish (US)
Pages (from-to)358-363
Number of pages6
JournalJournal of Diabetes Nursing
Volume20
Issue number10
StatePublished - 2016

Fingerprint

Chronic Renal Insufficiency
Pharmacokinetics

All Science Journal Classification (ASJC) codes

  • Endocrinology, Diabetes and Metabolism
  • Advanced and Specialized Nursing

Cite this

Utility of antidiabetes medications in chronic kidney disease : A review. / Knezevich, Emily; Kueser, Annette.

In: Journal of Diabetes Nursing, Vol. 20, No. 10, 2016, p. 358-363.

Research output: Contribution to journalReview article

@article{d136ac156cda483eb9269db8ff8b7432,
title = "Utility of antidiabetes medications in chronic kidney disease: A review",
abstract = "There is a large body of evidence describing the utility of antidiabetes agents in people with chronic kidney disease (CKD). Clinical decisions should take into account the pharmacokinetic variability and potential adverse events seen when these agents are used in renally impaired patients. In this article, the authors review the literature and summarise which antidiabetes agents are safe, with dose reductions if necessary, in people with CKD.",
author = "Emily Knezevich and Annette Kueser",
year = "2016",
language = "English (US)",
volume = "20",
pages = "358--363",
journal = "Journal of Diabetes Nursing",
issn = "1368-1109",
publisher = "SB Communications Group",
number = "10",

}

TY - JOUR

T1 - Utility of antidiabetes medications in chronic kidney disease

T2 - A review

AU - Knezevich, Emily

AU - Kueser, Annette

PY - 2016

Y1 - 2016

N2 - There is a large body of evidence describing the utility of antidiabetes agents in people with chronic kidney disease (CKD). Clinical decisions should take into account the pharmacokinetic variability and potential adverse events seen when these agents are used in renally impaired patients. In this article, the authors review the literature and summarise which antidiabetes agents are safe, with dose reductions if necessary, in people with CKD.

AB - There is a large body of evidence describing the utility of antidiabetes agents in people with chronic kidney disease (CKD). Clinical decisions should take into account the pharmacokinetic variability and potential adverse events seen when these agents are used in renally impaired patients. In this article, the authors review the literature and summarise which antidiabetes agents are safe, with dose reductions if necessary, in people with CKD.

UR - http://www.scopus.com/inward/record.url?scp=85009247754&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85009247754&partnerID=8YFLogxK

M3 - Review article

VL - 20

SP - 358

EP - 363

JO - Journal of Diabetes Nursing

JF - Journal of Diabetes Nursing

SN - 1368-1109

IS - 10

ER -